The elevated SIRT1 then stabilizes the hypoxia-inducible factor 1 α (HIF1α) protein through deacetylation, which subsequently promotes glycolytic metabolism and contributes to the chemoresistance observed in pancreatic cancer cells. Here, SIRT1 is linked to pancreatic neoplasm.